| Disease Burden at the Time of Transplantation Is a Primary Predictor of Outcomes in Pediatric MDS: A Single-Center Experience |
|
Cancers |
Myelodysplastic Syndromes (MDS), Pediatric |
| Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes |
|
American Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
| Distinctive Molecular Risk Factors Between MDS and MDS/AML Defined by ICC |
|
American Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
| DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes |
|
Blood Advances |
Myelodysplastic Syndromes (MDS) |
| Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic review |
|
Blood Reviews |
Myelodysplastic Syndromes (MDS) |
| Donor age and type in allogeneic haematopoietic stem cell transplantation: Strong effect in MDS, limited in AML |
|
British Journal of Haematology |
Myelodysplastic Syndromes (MDS) |
| Drug development in higher-risk myelodysplastic syndromes |
|
Blood Cancer Journal |
Myelodysplastic Syndromes (MDS) |
| Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS-M) prediction in myelodysplastic syndromes |
|
Journal of Internal Medicine |
Myelodysplastic Syndromes (MDS) |
| Eat and be healthy: nutritional status in myelodysplastic syndromes |
|
Leukemia & Lymphoma |
Myelodysplastic Syndromes (MDS) |
| Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series |
|
Annals of Hematology |
Aplastic Anemia |
